Wright Medical welcomes new executive VP & COO
Arlington, Tenn.-based joint replacement maker Wright Medical (NSDQ:WMGI) named Pascal Girin as executive VP & COO, effective either November 19 or when his visa transfer is finalized, whichever occurs later.
Girin will receive an annual base salary of $500,000, plus $300,000 bonus and is eligible for an annual performance bonus of up to 75% of his base salary. Additionally, Girin will receive an annual equity grant up to 175% of his base salary, according to regulatory filings.
"I’m delighted to announce Pascal’s appointment to this new position to lead our global businesses," president & CEO Robert Palmisano said in prepared remarks. "Pascal is a proven leader with significant operational experience. While working with me at ev3, Pascal was a major contributor to the company’s growth and success, including the rapid expansion of ev3’s worldwide neurovascular business to the No. 2 overall revenue share position, the successful acquisition of Chestnut Medical, and the growth of ev3’s peripheral vascular and international businesses at rates that significantly outpaced the market."
Medical Action expands its board member to 6
Medical Action Industries (NSDQ:MDCI) voted to expand its board from 5 to 6 members. The company also named Paul Chapman a board director until the 2015 annual meeting.
Syneron named new CFO
Aesthetic device company Syneron Medical Ltd. (NSDQ:ELOS) named Hugo Goldman as CFO, effective immediately. Goldman will replace interim CFO David Schlachet, who had held this position since August 2012.
Prior to join the company, Goldman was CFO of Retalix and AxisMobile. He also worked at VocalTec Communications and Algorithmic Research.